NCT05469698

Onsite Tobacco Cessation Treatment for Patients With PAD

Onsite Tobacco Cessation Treatment for Patients With Peripheral Artery Disease (PAD): A Feasibility Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: University of Oklahoma · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

Tobacco cessation treatment is needed for individuals with peripheral artery disease (PAD) to improve symptoms, lower cardiovascular risk, and prevent amputation. While such treatment is effective, many PAD patients do not receive cessation therapy. Participants will receive nicotine replacement therapy, counseling, and and complete questionnaires. We hypothesize that integrating tobacco cessation services into a dedicated PAD clinic (OU CVI Limb Preservation Clinic) can improve tobacco cessation rates and improve PAD-related health outcomes in this at risk population.

Conditions

• Tobacco Cessation
• Peripheral Artery Disease

Interventions

Type	Name	Description
BEHAVIORAL	Tobacco Treatment Research Program Standard Care	Participants interested in quitting tobacco will be offered standard tobacco cessation care including nicotine replacement therapy and counseling.

Timeline

• Start date: 2022-08-16
• Primary completion: 2023-06-30
• Completion: 2024-07-31
• First posted: 2022-07-22
• Last updated: 2024-02-15

Locations

1 site across 1 country: United States